BLUE-REG.COM: Keyword Density Checker

Total words: 4939 | 2-word phrases: 1292 | 3-word phrases: 1465 | 4-word phrases: 1524

PAGE INFO

Title	Try to keep the title under 60 characters (68 characters) BlueReg Group \| Pharmaceutical consulting for life sciences industry
Description	Try to keep the meta description between 50 - 160 characters (138 characters) BlueReg is a consultancy organization offering strategic regulatory advice and hands-on outsourcing solutions to life sciences companies.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (31 characters) European Regulatory Consultancy

ONE WORD PHRASES 658 Words

#	Keyword	Frequency	Density
1	to	46	6.99%
2	and	46	6.99%
3	the	43	6.53%
4	of	35	5.32%
5	in	33	5.02%
6	pharmaceutical	30	4.56%
7	for	29	4.41%
8	life	27	4.10%
9	consulting	26	3.95%
10	industry	24	3.65%

TWO WORD PHRASES 1292 Words

#	Keyword	Frequency	Density
1	consulting for	19	1.47%
2	life sciences	19	1.47%
3	pharmaceutical consulting	18	1.39%
4	for life	17	1.32%
5	sciences industry	15	1.16%
6	in the	15	1.16%
7	access programs	10	0.77%
8	early access	9	0.70%
9	of the	8	0.62%
10	regulatory affairs	8	0.62%
11	united states	8	0.62%
12	product development	7	0.54%
13	the eu	7	0.54%
14	looking to	6	0.46%
15	scientific writing	6	0.46%
16	pharmaceutical companies	6	0.46%
17	exploitant services	5	0.39%
18	in france	5	0.39%
19	cycle management	5	0.39%
20	paediatric investigation	5	0.39%

THREE WORD PHRASES 1465 Words

#	Keyword	Frequency	Density
1	pharmaceutical consulting for	17	1.16%
2	consulting for life	17	1.16%
3	for life sciences	16	1.09%
4	life sciences industry	14	0.96%
5	early access programs	5	0.34%
6	paediatric investigation plan	5	0.34%
7	writing cmc regulatory	4	0.27%
8	promotional material review	4	0.27%
9	scientific writing dossier	4	0.27%
10	in the eu	4	0.27%
11	access programs in	4	0.27%
12	earlyexpanded access programs	4	0.27%
13	programs in france	3	0.20%
14	dossier writing cmc	3	0.20%
15	clinical study reports	3	0.20%
16	send us a	3	0.20%
17	paediatric investigation plans	3	0.20%
18	companies looking to	3	0.20%
19	cmc regulatory support	3	0.20%
20	industry pharmaceutical consulting	3	0.20%
21	sciences industry pharmaceutical	3	0.20%
22	companies in the	3	0.20%
23	access programs atu	3	0.20%
24	message office locator	2	0.14%
25	discover their case	2	0.14%
26	audit exploitant services	2	0.14%
27	access france pharmacovigilance	2	0.14%
28	market access france	2	0.14%
29	as a pharma	2	0.14%
30	exploitant services role	2	0.14%

FOUR WORD PHRASES 1524 Words

#	Keyword	Frequency	Density
1	pharmaceutical consulting for life	16	1.05%
2	consulting for life sciences	16	1.05%
3	for life sciences industry	12	0.79%
4	industry pharmaceutical consulting for	3	0.20%
5	earlyexpanded access programs in	3	0.20%
6	access programs in france	3	0.20%
7	early access programs atu	3	0.20%
8	dossier writing cmc regulatory	3	0.20%
9	writing cmc regulatory support	3	0.20%
10	all stages of product	2	0.13%
11	access france pharmacovigilance earlyexpanded	2	0.13%
12	material review qualityaudits product	2	0.13%
13	commercialization of their products	2	0.13%
14	the commercialization of their	2	0.13%
15	market access france pharmacovigilance	2	0.13%
16	in france united kingdom	2	0.13%
17	during the commercialization of	2	0.13%
18	compliance during the commercialization	2	0.13%
19	services france registration life	2	0.13%
20	france united kingdom united	2	0.13%
21	united kingdom united kingdom	2	0.13%
22	kingdom united kingdom brexit	2	0.13%
23	united kingdom brexit europe	2	0.13%
24	promotional material review qualityaudits	2	0.13%
25	scientific writing dossier life	2	0.13%
26	5 mustknows about paediatric	2	0.13%
27	audit exploitant services role	2	0.13%
28	clinical study reports safety	2	0.13%
29	study reports safety reports	2	0.13%
30	requirements to launch your	2	0.13%
31	key requirements to launch	2	0.13%
32	10 key requirements to	2	0.13%
33	and audit exploitant services	2	0.13%
34	of responsible pharmacists in	2	0.13%
35	mustknows about paediatric investigation	2	0.13%
36	plan in the eu	2	0.13%
37	investigation plan in the	2	0.13%
38	paediatric investigation plan in	2	0.13%
39	france scientific writing dossier	2	0.13%
40	worldwide outsourcing programs program	2	0.13%

EXTERNAL LINKS

#	URL	Whois	Check
1	https://www.linkedin.com/company/bluereg-group	Whois	linkedin.com
2	https://www.bluereg-group.com/terms-of-use/#ancre-rgpd	Whois	bluereg-group.com
3	https://www.google.com/maps/place/PharmaLex+France/@48.8889445,2.2498071,15z/data=!4m6!3m5!1s0x47e66f879381d10b:0xa19081bf6ad548bb!8m2!3d48.8889445!4d2.2498071!16s%2Fg%2F1tfg6zwp?entry=ttu	Whois	google.com
4	https://goo.gl/maps/MnyKGMG1aaPiH47Q7	Whois	goo.gl
5	https://www.google.com/maps/place/PharmaLex+France/@48.8889445,2.2498071,15z/data=!4m6!3m5!1s0x47e66f879381d10b:0xa19081bf6ad548bb!8m2!3d48.8889445!4d2.2498071!16s%2Fg%2F1tfg6zwp?entry=ttu	Whois	google.com
6	https://goo.gl/maps/MnyKGMG1aaPiH47Q7	Whois	goo.gl
7	https://www.pharmalex.com/pharmalex-insights/company-news/industry-news-articles/we-are-becoming-cencora-pharmalex/	Whois	pharmalex.com